ESC 22 in Review With Dr P Parwani: 5 Trials That Will Change Your Practice
Ep 77: ESC 22 in Review With Dr Purvi Parwani: 5 Trials That Will Change Your Practice

Average (ratings)
No ratings
 
  Your rating

Back by popular demand, Dr Ankur Kalra's guest is Dr Purvi Parwani, Director of Women’s Cardiovascular Disease Clinic and Assistant Professor at Loma Linda University Medical Center, US. In this ESC 2022 edition of Parallax, Ankur asks Purvi to review her highlights of the congress. Purvi details the study design and key findings of each trial and provides her insights after attending the event in Barcelona. Ankur and Purvi discuss how each trial will inform their practice.

Trials covered in detail include:

  • REVIVED: Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure (NCT01920048)
  • DANCAVAS: Danish Cardiovascular Screening Trial II (NCT03946410)
  • DELIVER: Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure (NCT03619213)
  • SECURE: Secondary Prevention of Cardiovascular Disease in the Elderly Trial (NCT02596126)
  • INVICTUS: INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority (NCT02832544)

What are the key take-home messages of ESC 22? How can we implement these findings into daily practice? Where are the opportunities for further research?


Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode.

Guest: @purviparwani, host: @AnkurKalraMD and produced by: @RadcliffeCARDIO.


Read MoreRead Less
Share
Up Next
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani
EP78 • Oct 10, 2022 • 46m 28s
This week’s Parallax episode is focusing on the latest science and questions surrounding one of the conundrums of cardiovascular science: Lipoprotein(a).
Dr. Ankur Kalra invites Dr Salim S Virani to help simplify the concept of Lp(a) with answering key questions about its measurement and its place in practice and prevention.
Read More
All Episodes
01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger
EP01 • Apr 23, 2020 • 27m 44s
In our first episode, Ankur explains his vision for and inspiration to start ‘Parallax’, and speaks with Chad Kliger from Lenox Hill Hospital in New York about conduction abnormalities after transcatheter aortic valve replacement (TAVR/TAVI), a review article published in US Cardiology Review 13.1 Ankur and Chad look at conduction abnormalities after TAVR/TAVI with a focus on basic conduction system anatomy in relation to the aortic valve, the mechanism, incidence, predisposing factors for occurrence, impact on mortality and finally, proposed treatment algorithms for management. Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.
Read More
Lisa Rosenbaum's journey to medical journalism at NEJM
EP26 • Apr 23, 2020 • 44m 54s
Lisa Rosenbaum has been writing extensively about the human face of medicine. Her articles have been widely circulated by publications like The New York Times, The New Yorker and The New England Journal of Medicine.

In this edition of Parallax Dr Kalra asked Dr Rosenbaum about the influences that shaped her choices as a writer and as a healthcare professional. Dr Rosenbaum opens up about her childhood and how she connected to her grandfather through writing and medicine. We learn about Lisa’s first day at medical school and her latest writing project.
Read More
Clinician-Scientist During The COVID-19 Pandemic
EP25 • Apr 23, 2020 • 43m 40s
A week after Jag Singh had tested positive for 2019-nCoV, he became a patient in his hospital’s intensive care unit. This week he joins Ankur Kalra, MD to tell us about his journey as a clinician-scientist.

Jagmeet P Singh, associate chief of the cardiology division at Massachusetts General Hospital and professor of medicine at Harvard Medical School joins Ankur Kalra for a deep conversation about his journey across three continents. Dr Singh talks about the importance of choosing fulfilment over success. We gain more insights on the recent late-breaking trial, MADIT-CHIC focusing on cardiac resynchronization therapy. Ankur asks Jag about his experience of being on the other side of the healthcare system and his enrolment in the since halted remdesivir trial.
Read More
COVID-19 Lessons Learnings From Italy
EP24 • Apr 23, 2020 • 35m 4s
“It’s a tsunami not just a wave. The worst tsunami you can imagine”


Prof Michele Senni is Director of Cardiology at Papa Giovanni XXIII Hospital, Bergamo Italy. He contracted COVID-19 himself and in this latest podcast he meets with Ankur Kalra, MD to discuss his personal experience in dealing with patients and COVID-19 in Europe’s outbreak epicentre.


Hear them discuss the burden on healthcare, patient selection, the importance of testing and PPE and how COVID has resulted in a reduction of acute myocardial infarction and heart failure in patients.
Read More
23: COVID-19 And Cardiovascular Disease
EP23 • Apr 23, 2020 • 49m 22s
“We are at war with a pandemic and the enemy is not each other, it’s the virus.”


In this latest episode, Ankur Kalra, MD meets with Andrew Sauer, MD, co-author of an upcoming paper in US Cardiology Review on COVID-19 and Cardiovascular Disease that provides a concise and current summary of cardiovascular complications from COVID-19.


Hear them discuss the latest issues surrounding the pandemic, the known cardiac implications and the rapidly emerging data.
Read More
22: COVID-19 Lessons and Learnings From South East Asia
EP22 • Apr 23, 2020 • 32m 18s
In these unprecedented times, we provide an early release episode to gain insight on dealing with the COVID-19 pandemic from Deputy Editor in Chief of US Cardiology Review, a BDG interventional cardiologist, Bill Gogas, MD, PhD practising in East Asia.



Hear Bill’s take on how East Asia responded to and successfully managed the pandemic and how they are now seeing a significant reduction in cases outside the epicentre. Hear how the strategy resulted in only 93 patients in Bill’s city of Nanjing, testing positive for coronavirus with a city population of 8 million.



Learn about effective responses, the importance of early control and how as a cardiovascular physician, your life and practice may be impacted by the virus.

Submit your question to Ankur via: podcast@radciffe-group.com.


Hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.
Read More